Question 1

Has Ira Glick received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,345,857 in general payments to Ira Glick across 459 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Ira Glick did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Ira Glick come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie(2 entities)	143	$773,804
Axsome Therapeutics, Inc.	27	$354,654
Janssen Research & Development, LLC	27	$212,255
Otsuka Pharmaceutical Development & Commercialization, Inc.	13	$191,108
Pfizer	31	$123,299
Alkermes, Inc.	53	$110,643
Teva Pharmaceuticals USA, Inc.	67	$99,520
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$92,464
Biohaven Pharmaceutical Holding Company Ltd.	25	$85,647
Boehringer Ingelheim	4	$74,987
E.r. Squibb & Sons, L.L.C.	6	$73,693
Sage Therapeutics, LLC	2	$40,595
Avanir Pharmaceuticals, Inc.	22	$39,294
Biohaven Pharmaceuticals, Inc.	8	$30,437
H. Lundbeck A S	16	$28,037
Vanda Pharmaceuticals Inc.	1	$10,061
Boehringer Ingelheim RCV GmbH & Co KG	2	$5,095
Neurocrine Biosciences, Inc.	3	$140
Lundbeck LLC	1	$89
Merck	1	$35

Ira Glick

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Stanford